Industry news
Must read
Natural alternative to anti-obesity medication linked to weight loss and improved gut health
Oobli gets FDA approval for sweet protein Monellin and expands board to boost growth
Biden’s GLP-1 expansion plan to cut costs and expand access faces Trump uncertainty
Category news
Reports
Key trends
Multimedia
Publication
Events
Suppliers
Arthritis
Date
April24-25, 2002
Location
The Hatton, London
Email
ptombs@smi-online.co.uk
Website
www.smi-online.co.uk